During the past decade, Kaposi Mor Teaching Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaposi Mor Teaching Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "AOP Orphan Pharmaceuticals AG" with 3 trials sponsored, "Shire" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Antisoma Research" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaposi Mor Teaching Hospital" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "PharmaEssentia (Co-Sponsor for USA)" with 1 trials as a collaborator, "PharmaEssentia Corporation (Co-Sponsor for USA)" with 1 trials as a collaborator and "PharmaEssentia Corporation (for the U.S.)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kaposi Mor Teaching Hospital" are "Polycythemia Vera" (3 trials), "Acute Bacterial Skin and Skin Structure Infections" (1 trials), "Basal Cell Carcinoma" (1 trials), "Colorectal Cancer" (1 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Kaposi Mor Teaching Hospital" in a lesser frequency.

Most popular intervention types in "Kaposi Mor Teaching Hospital" are "Drug" (15 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Hydroxyurea" (2 trials), "Amonafide and Cytarabine" (1 trials), "Anagrelide" (1 trials) and "Axitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaposi Mor Teaching Hospital" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Kaposi Mor Teaching Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Kaposi Mor Teaching Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kaposi Mor Teaching Hospital, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".